enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA finalizes decision to end Lilly's GLP-1 shortage ... - AOL

   www.aol.com/finance/fda-finalizes-decision-end...

   The Food and Drug Administration has finalized its decision to call an end to the drug shortage of Eli Lilly's blockbuster GLP-1 products, often referred to by their formula name, tirzepatide.Eli ...

3. This Is Huge News for Eli Lilly Investors - AOL

   www.aol.com/huge-news-eli-lilly-investors...

   Lilly's focus on augmenting manufacturing capabilities is a good sign and will lead to higher production of its medicines. But this is just one noteworthy announcement the company has made lately.

4. Telehealth Firm Ro Partners With Eli Lilly to Boost Access to ...

   www.aol.com/finance/telehealth-firm-ro-partners...

   Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) single-dose vials for obesity treatment. Through LillyDirect, Ro will provide ...

5. Ro partners with Eli Lilly to expand access to Zepbound vials

   www.aol.com/finance/ro-partners-eli-lilly-expand...

   Eli Lilly has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound.Ro is joining other telehealth platforms and Amazon Pharmacy in ...

6. 2 Brand-New Reasons to Buy Eli Lilly Stock Right Now ... - AOL

   www.aol.com/2-brand-reasons-buy-eli-190500731.html

   As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is always providing investors with additional reasons to consider buying its stock.

7. Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025

   www.aol.com/eli-lilly-stock-could-huge-124500429...

   Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its trailing earnings. It's trading at close to 90 times its trailing earnings.

8. Eli Lilly (LLY) Q3 2024 Earnings Call Transcript - AOL

   www.aol.com/eli-lilly-lly-q3-2024-183013652.html

   Eli Lilly (NYSE: LLY) Q3 2024 Earnings Call Oct 30, 2024, 10:00 a.m. ET. Contents: ... demand for Mounjaro and Zepbound has been strong and continues to grow as we expand both access and supply. U ...

9. Eli Lilly (LLY) Q2 2024 Earnings Call Transcript - AOL

   www.aol.com/eli-lilly-lly-q2-2024-210021390.html

   Eli Lilly (NYSE: LLY) Q2 2024 Earnings Call ... vice president of global quality and a member of the company's executive committee following Johna Norton's recent retirement. ... You may access ...